In a Time of Universal Deceit, Telling the Truth is Revolutionary.
Sunday, December 4, 2022

F.D.A. Panel Endorses Lilly Blood Thinner

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

Facebook
Twitter
LinkedIn

The drug, called prasugrel, could pose the first real challenge to Bristol-Myers Squibb’s near monopoly on blood-thinning drugs.

%d bloggers like this: